A detailed history of Strs Ohio transactions in Repligen Corp stock. As of the latest transaction made, Strs Ohio holds 42,000 shares of RGEN stock, worth $6.07 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
42,000
Previous 48,000 12.5%
Holding current value
$6.07 Million
Previous $6.05 Million 3.31%
% of portfolio
0.02%
Previous 0.02%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$119.79 - $167.35 $718,740 - $1 Million
-6,000 Reduced 12.5%
42,000 $6.25 Million
Q2 2024

Aug 05, 2024

SELL
$120.0 - $182.95 $544,320 - $829,861
-4,536 Reduced 8.63%
48,000 $6.05 Million
Q1 2024

May 13, 2024

BUY
$170.78 - $208.42 $2.77 Million - $3.38 Million
16,236 Added 44.73%
52,536 $9.66 Million
Q4 2023

Jan 30, 2024

BUY
$114.17 - $185.35 $274,008 - $444,840
2,400 Added 7.08%
36,300 $6.53 Million
Q3 2023

Oct 26, 2023

SELL
$138.78 - $176.51 $957,582 - $1.22 Million
-6,900 Reduced 16.91%
33,900 $5.39 Million
Q2 2023

Jul 31, 2023

SELL
$138.42 - $180.31 $2.62 Million - $3.41 Million
-18,898 Reduced 31.66%
40,800 $5.77 Million
Q1 2023

Aug 02, 2023

BUY
$154.26 - $198.1 $2.92 Million - $3.74 Million
18,898 Added 46.32%
59,698 $10.1 Million
Q1 2023

Apr 27, 2023

SELL
$154.26 - $198.1 $3.42 Million - $4.4 Million
-22,202 Reduced 27.11%
59,698 $10.1 Million
Q4 2022

Jan 26, 2023

SELL
$162.42 - $220.56 $1.56 Million - $2.12 Million
-9,600 Reduced 10.49%
81,900 $13.9 Million
Q3 2022

Oct 27, 2022

BUY
$160.42 - $256.21 $1.03 Million - $1.64 Million
6,400 Added 7.52%
91,500 $17.1 Million
Q2 2022

Jul 25, 2022

BUY
$140.68 - $188.02 $1.06 Million - $1.41 Million
7,500 Added 9.66%
85,100 $13.8 Million
Q1 2022

Apr 21, 2022

BUY
$161.19 - $257.96 $1.87 Million - $2.99 Million
11,600 Added 17.58%
77,600 $14.6 Million
Q4 2021

Jan 24, 2022

BUY
$247.59 - $304.47 $1.81 Million - $2.22 Million
7,300 Added 12.44%
66,000 $17.5 Million
Q3 2021

Oct 22, 2021

SELL
$194.77 - $324.21 $2.49 Million - $4.15 Million
-12,800 Reduced 17.9%
58,700 $17 Million
Q2 2021

Jul 26, 2021

SELL
$165.87 - $220.95 $1.25 Million - $1.66 Million
-7,520 Reduced 9.52%
71,500 $14.3 Million
Q1 2021

Apr 23, 2021

SELL
$180.37 - $226.26 $123,733 - $155,214
-686 Reduced 0.86%
79,020 $15.4 Million
Q4 2020

Jan 25, 2021

SELL
$148.08 - $206.57 $1.27 Million - $1.78 Million
-8,599 Reduced 9.74%
79,706 $15.3 Million
Q3 2020

Dec 14, 2020

SELL
$122.51 - $158.27 $2.9 Million - $3.75 Million
-23,701 Reduced 21.16%
88,305 $13 Million
Q2 2020

Jul 23, 2020

SELL
$94.33 - $140.48 $1.39 Million - $2.06 Million
-14,694 Reduced 11.6%
112,006 $13.8 Million
Q1 2020

Apr 23, 2020

BUY
$84.96 - $109.14 $9.11 Million - $11.7 Million
107,200 Added 549.74%
126,700 $12.2 Million
Q4 2019

Jan 24, 2020

SELL
$73.84 - $93.08 $29,536 - $37,232
-400 Reduced 2.01%
19,500 $1.8 Million
Q3 2019

Oct 21, 2019

BUY
$76.65 - $95.51 $68,985 - $85,959
900 Added 4.74%
19,900 $1.53 Million
Q2 2019

Jul 25, 2019

SELL
$54.2 - $85.95 $37,940 - $60,165
-700 Reduced 3.55%
19,000 $1.63 Million
Q4 2018

Jan 23, 2019

BUY
$48.26 - $68.88 $950,722 - $1.36 Million
19,700 New
19,700 $1.04 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.